217 related articles for article (PubMed ID: 22277251)
1. Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation.
Haines P; Hant FN; Lafyatis R; Trojanowska M; Bujor AM
J Cell Mol Med; 2012 Sep; 16(9):2238-46. PubMed ID: 22277251
[TBL] [Abstract][Full Text] [Related]
2. Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.
Morris E; Chrobak I; Bujor A; Hant F; Mummery C; Ten Dijke P; Trojanowska M
J Cell Physiol; 2011 Dec; 226(12):3340-8. PubMed ID: 21344387
[TBL] [Abstract][Full Text] [Related]
3. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.
Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M
Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
7. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor.
Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F
Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049
[TBL] [Abstract][Full Text] [Related]
9. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
10. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.
Man XY; Finnson KW; Baron M; Philip A
Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813
[TBL] [Abstract][Full Text] [Related]
11. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts.
Kim S; Lee Y; Seo JE; Cho KH; Chung JH
Cell Signal; 2008 Jul; 20(7):1313-9. PubMed ID: 18434090
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
[TBL] [Abstract][Full Text] [Related]
16. Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
Trojanowska M
Curr Opin Rheumatol; 2009 Nov; 21(6):623-9. PubMed ID: 19713852
[TBL] [Abstract][Full Text] [Related]
17. CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling network.
Nakerakanti SS; Bujor AM; Trojanowska M
PLoS One; 2011; 6(7):e21911. PubMed ID: 21760921
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
Bujor AM; Haines P; Padilla C; Christmann RB; Junie M; Sampaio-Barros PD; Lafyatis R; Trojanowska M
Int J Mol Med; 2012 Dec; 30(6):1473-80. PubMed ID: 23041765
[TBL] [Abstract][Full Text] [Related]
19. TGF-β-mediated upregulation of brachyury contributes to constitutively up-regulated type I collagen expression in skin fibroblasts: possible role in systemic sclerosis.
Teng L; Yao G; Gao R; Wang Y; Lin W; Jin Y; Wang Y; Chen H; Wang Z; Chen J
Eur J Dermatol; 2019 Aug; 29(4):359-365. PubMed ID: 31625918
[TBL] [Abstract][Full Text] [Related]
20. SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.
Zhu Q; Kim YH; Wang D; Oh SP; Luo K
J Cell Biol; 2013 Sep; 202(6):937-50. PubMed ID: 24019535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
